Previous 10 | Next 10 |
Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference PR Newswire HOUSTON , April 27, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company wit...
Soliton Provides Special 510(k) and Commercialization Update PR Newswire HOUSTON , April 15, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announce...
These Health Care Stocks Have Been On Fire In The Market This Year There is no denying that health care will continue to play a vital role in the economy. Be it good times or bad, health care stocks could always present an opportunity for investors to make substantial gains. Acc...
Gainers: Benitec Biopharma (BNTC) +71%, Hoth Therapeutics (HOTH) +26%, Aerpio Pharmaceuticals (ARPO) +12%, Soliton (SOLY) +11%, China Jo-Jo Drugstores (CJJD) +9%.Losers: Frequency Therapeutics (FREQ) -75%, Windtree Therapeutics (WINT) ...
Soliton to Participate in Three Upcoming Healthcare Conferences PR Newswire HOUSTON , March 11, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today ...
Soliton (SOLY) announces that the company initiated a second pre-clinical study in animals for its Rapid Acoustic Pulse ((RAP)) therapy device as a potential treatment of liver fibrosis.The decision for an additional pre-clinical study follows the first animal study that showed posi...
Soliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver Fibrosis Initial Animal Study Reduced Effects of Liver Fibrosis by 42% PR Newswire HOUSTON , March 9, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" o...
Soliton, Inc. (SOLY) Q4 2020 Earnings Conference Call March 4, 2021, 04:30 PM ET Company Participants Carol Ruth - Founder and President, The Ruth Group, Investor Relations Brad Hauser - President and Chief Executive Officer Lori Bisson - Chief Financial Officer Conference Call Participants L...
Soliton (SOLY): Q4 GAAP EPS of -$0.22 beats by $0.01.Total cash, cash equivalents and restricted cash was $31.8M as of December 31, 2020 compared to $12.1M as of December 31, 2019.Press Release For further details see: Soliton EPS beats by $0.01
Soliton Reports Fourth Quarter and Full Year 2020 Results PR Newswire HOUSTON , March 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported fin...
News, Short Squeeze, Breakout and More Instantly...
Allergan Aesthetics Completes Acquisition of Soliton -- Addition of Soliton complements Body Contouring Portfolio with expansion to treat appearance of cellulite -- PR Newswire IRVINE, Calif. , Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie comp...
On a gloomy day for the stock market, healthcare aesthetics specialist Soliton (NASDAQ: SOLY) was a luminous bright spot on Tuesday. The company's shares rocketed almost 12% higher, on news that its absorption into soon-to-be-parent AbbVie (NYSE: ABBV) is about to close. ...
Soliton Inc. (NASDAQ:SOLY) traded today at a new 52-week high of $22.60. So far today approximately 147,000 shares have been exchanged, as compared to an average 30-day volume of 103,000 shares. Based on a current price of $22.53, Soliton Inc. is currently 19.0% above its average consens...